Rikin S. Mehta

Innovating in the domain of biotechnology and healthcare law, Rikin S. Mehta is a distinguished biotech entrepreneur and legal expert with a multifaceted career. He currently serves as the head of U.S. Regulatory Policy at Pfizer Consumer Healthcare, where he plays a pivotal role in shaping regulatory strategies and policies. In addition to his corporate responsibilities, Rikin is an adjunct professor of law at the School of Law, Georgetown University, Washington, DC, where he imparts his extensive knowledge and experience to the next generation of legal professionals. Rikin's career is marked by a rich tapestry of roles that highlight his expertise in healthcare law and policy. His previous tenure at the U.S. Food and Drug Administration (FDA) provided him with invaluable insights into the regulatory landscape, while his work with the D.C. Department of Health and the Board of Medicine further honed his skills in public health administration and medical regulation. These experiences have equipped him with a comprehensive understanding of the intersection between law, medicine, and public policy. Beyond his regulatory and academic endeavors, Rikin is a co-founder of Lactiga Therapeutics and Licentiam, Inc., ventures that underscore his entrepreneurial spirit and commitment to advancing healthcare solutions. Lactiga Therapeutics focuses on developing innovative treatments for immunodeficiencies, while Licentiam, Inc. aims to streamline professional licensing processes. Rikin's diverse career path reflects his dedication to improving healthcare outcomes and his ability to navigate complex legal and regulatory environments.